SequelSEC

InspireMD, Inc. NSPR

Surgical & Medical Instruments & Apparatus · CIK 0001433607 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$10.84M
Fiscal year ended 2026-06-30
Operating income
-$53.56M
Fiscal year ended 2026-06-30
Free cash flow
-$42.46M
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$60.93MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$1.30Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue6.8×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity1.1×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Surgical & Medical Instruments & Apparatus filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
SBC / revenue137.3%91th
CapEx / revenue18.5%91th
Gross margin29.5%13th
Operating margin-552.6%14th
FCF margin-409.5%14th
Net margin-543.3%14th
R&D / revenue167.1%85th
Current ratio5.74x79th
Revenue YoY growth28.1%74th

InspireMD, Inc. (NSPR) reported revenue of $10.84M and net income of -$52.48M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from InspireMD, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

InspireMD, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$10.84M
Cost of revenue$8.88M
Gross profit$1.96M
Operating income-$53.56M
Net income-$52.48M
Research & development$16.17M
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrative$39.35M
General & administrative$19.32M
Selling & marketing$20.03M

Balance

InspireMD, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$15.15M
Total assets$44.64M
Current assets$36.63M
Total liabilities$13.13M
Current liabilities$9.65M
Total equity incl. NCI$31.51M
Temporary (mezzanine) equityUnavailable
Inventory$2.70M
Accounts receivable$1.82M
GoodwillUnavailable
Long-term debtUnavailable
Accounts payableUnavailable

Cash flow

InspireMD, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$41.21M
Capital expenditures$1.25M
Investing cash flow-$8.15M
Financing cash flowUnavailable
Net change in cash$3.64M
Stock-based compensation$10.72M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

InspireMD, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow-$42.46M
Gross margin18.1%
Operating margin-494.0%
FCF margin-391.7%
SBC / revenue98.8%
Current ratio3.80x
Revenue YoY growth53.4%
Net margin-484.1%
R&D / revenue149.1%
CapEx / revenue11.5%
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open NSPR in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-14View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-K · Filed 2026-03-18View SEC filing
10-Q · Filed 2025-11-10View SEC filing
10-Q · Filed 2025-08-04View SEC filing
10-Q · Filed 2025-05-08View SEC filing

Companies in the same industry

ADGM AEMD ALUR AMIX ANGO ANIK AORT APYX ARAY ATEC ATRC AURX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.